NCT01606371View on ClinicalTrials.gov

A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Placebo

Administered orally

DRUG

LY2409021

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01606371 - A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes | Biotech Hunter | Biotech Hunter